78 related articles for article (PubMed ID: 17974968)
1. A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis.
Pérez-Gómez E; Villa-Morales M; Santos J; Fernández-Piqueras J; Gamallo C; Dotor J; Bernabéu C; Quintanilla M
Cancer Res; 2007 Nov; 67(21):10268-77. PubMed ID: 17974968
[TBL] [Abstract][Full Text] [Related]
2. The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras.
Santibanez JF; Pérez-Gómez E; Fernandez-L A; Garrido-Martin EM; Carnero A; Malumbres M; Vary CP; Quintanilla M; Bernabéu C
Carcinogenesis; 2010 Dec; 31(12):2145-54. PubMed ID: 20884686
[TBL] [Abstract][Full Text] [Related]
3. Soluble endoglin antagonizes Met signaling in spindle carcinoma cells.
del Castillo G; Sánchez-Blanco E; Martín-Villar E; Valbuena-Diez AC; Langa C; Pérez-Gómez E; Renart J; Bernabéu C; Quintanilla M
Carcinogenesis; 2015 Feb; 36(2):212-22. PubMed ID: 25503931
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs.
Alejandre-Alcázar MA; Michiels-Corsten M; Vicencio AG; Reiss I; Ryu J; de Krijger RR; Haddad GG; Tibboel D; Seeger W; Eickelberg O; Morty RE
Dev Dyn; 2008 Jan; 237(1):259-69. PubMed ID: 18095342
[TBL] [Abstract][Full Text] [Related]
5. Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis.
Quintanilla M; Ramirez JR; Pérez-Gómez E; Romero D; Velasco B; Letarte M; López-Novoa JM; Bernabéu C
Oncogene; 2003 Sep; 22(38):5976-85. PubMed ID: 12955076
[TBL] [Abstract][Full Text] [Related]
6. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
[TBL] [Abstract][Full Text] [Related]
7. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
[TBL] [Abstract][Full Text] [Related]
8. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling.
Santibanez JF; Letamendia A; Perez-Barriocanal F; Silvestri C; Saura M; Vary CP; Lopez-Novoa JM; Attisano L; Bernabeu C
J Cell Physiol; 2007 Feb; 210(2):456-68. PubMed ID: 17058229
[TBL] [Abstract][Full Text] [Related]
9. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3.
Bae DS; Blazanin N; Licata M; Lee J; Glick AB
Mol Carcinog; 2009 May; 48(5):441-53. PubMed ID: 18942075
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
12. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
13. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Kocic J; Bugarski D; Santibanez JF
Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
[TBL] [Abstract][Full Text] [Related]
14. Suprabasal alpha 5 beta1 integrin expression stimulates formation of epidermal squamous cell carcinomas without disrupting TGFbeta signaling or inducing spindle cell tumors.
Owens DM; Broad S; Yan X; Benitah SA; Watt FM
Mol Carcinog; 2005 Sep; 44(1):60-6. PubMed ID: 15924349
[TBL] [Abstract][Full Text] [Related]
15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
16. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
18. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
19. Characterization of murine S-endoglin isoform and its effects on tumor development.
Pérez-Gómez E; Eleno N; López-Novoa JM; Ramirez JR; Velasco B; Letarte M; Bernabéu C; Quintanilla M
Oncogene; 2005 Jun; 24(27):4450-61. PubMed ID: 15806144
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
